Pranav Tandon

518 total citations · 1 hit paper
13 papers, 312 citations indexed

About

Pranav Tandon is a scholar working on Infectious Diseases, Clinical Biochemistry and Statistics and Probability. According to data from OpenAlex, Pranav Tandon has authored 13 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 4 papers in Statistics and Probability. Recurrent topics in Pranav Tandon's work include Bacterial Identification and Susceptibility Testing (5 papers), Statistical Methods in Clinical Trials (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Pranav Tandon is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Statistical Methods in Clinical Trials (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Pranav Tandon collaborates with scholars based in Canada, United Kingdom and Kenya. Pranav Tandon's co-authors include Mark Loeb, Adam S. Komorowski, Anthony D. Bai, Carson K. L. Lo, Sarai Keestra, Guillaume Butler‐Laporte, Julien Senécal, Andrew M. Morris, Olivier Del Corpo and Emily G. McDonald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pranav Tandon

13 papers receiving 309 citations

Hit Papers

Staphylococcus aureus bacteraemia mortality: a systematic... 2022 2026 2023 2024 2022 50 100 150

Peers

Pranav Tandon
Barry Cookson United Kingdom
Ali M. Bazzi Saudi Arabia
Roberto Viau United States
Louise Nutt South Africa
Barry Cookson United Kingdom
Pranav Tandon
Citations per year, relative to Pranav Tandon Pranav Tandon (= 1×) peers Barry Cookson

Countries citing papers authored by Pranav Tandon

Since Specialization
Citations

This map shows the geographic impact of Pranav Tandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranav Tandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranav Tandon more than expected).

Fields of papers citing papers by Pranav Tandon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranav Tandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranav Tandon. The network helps show where Pranav Tandon may publish in the future.

Co-authorship network of co-authors of Pranav Tandon

This figure shows the co-authorship network connecting the top 25 collaborators of Pranav Tandon. A scholar is included among the top collaborators of Pranav Tandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranav Tandon. Pranav Tandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Keestra, Sarai, Pranav Tandon, Amy J. Pickering, et al.. (2023). One Health WASH: an AMR-smart integrative approach to preventing and controlling infection in farming communities. BMJ Global Health. 8(3). e011263–e011263. 11 indexed citations
2.
3.
Tandon, Pranav, Kevin A. Brown, Nick Daneman, et al.. (2023). Variability in changes in physician outpatient antibiotic prescribing from 2019 to 2021 during the COVID-19 pandemic in Ontario, Canada. SHILAP Revista de lepidopterología. 3(1). e171–e171. 2 indexed citations
4.
Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clinical Microbiology and Infection. 28(8). 1076–1084. 150 indexed citations breakdown →
5.
Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies. Clinical Infectious Diseases. 75(8). 1449–1452. 10 indexed citations
6.
Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International Journal of Infectious Diseases. 122. 405–411. 16 indexed citations
7.
Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality. Open Forum Infectious Diseases. 9(5). ofac096–ofac096. 9 indexed citations
8.
Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review. BMC Medical Research Methodology. 21(1). 75–75. 21 indexed citations
9.
Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials. Trials. 22(1). 708–708. 2 indexed citations
10.
Pepperrell, Toby, et al.. (2021). Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials. Global Health Action. 14(1). 1892309–1892309. 15 indexed citations
11.
Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2020). Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review. Clinical Infectious Diseases. 73(7). e1696–e1705. 11 indexed citations
12.
13.
Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2020). Novel Antibiotics May Be Noninferior but Are They Becoming Less Effective?: a Systematic Review. Antimicrobial Agents and Chemotherapy. 64(11). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026